Scientists report that a combination of two licensed antiviral drugs reduces virus replication and improves clinical outcome in a recently developed monkey model of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Their study expands on recent work showing that a combination of ribavirin and interferon-alpha 2b stops MERS-CoV from replicating in cell culture.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/q...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/q...